Arcellx (ACLX) FCF Margin (2023 - 2025)

Arcellx's (ACLX) quarterly FCF Margin came in at 3558.9% in Q4 2025, down 317812.0% year-on-year from N/an in Q4 2024, and down 256.22% quarter-over-quarter from 999.07% in Q3 2025.

Arcellx (ACLX) FCF Margin (2023 - 2025) Analysis & Trends

Arcellx's FCF Margin history runs 3 years deep, the most recent figure standing at 3558.9% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 317812.0% year-over-year to 3558.9% in Q4 2025; TTM through Dec 2025 was 950.57%, a 86079.0% decrease from a year earlier, with the FY2025 full-year figure at 953.89%, down 86412.0% from the prior year.
  • FCF Margin fell to 3558.9% in Q4 2025 per ACLX's latest filing, from 999.07% in the prior quarter.
  • Across five years, FCF Margin topped out at 1010.84% in Q1 2023 and bottomed at 3558.9% in Q4 2025.
  • The 3-year median for FCF Margin is 176.38% (2023), against an average of 460.16%.
  • Across the five-year window, FCF Margin soared 21078 bps in 2024 and slumped 317812 bps in 2025, its largest moves.
  • Year by year, FCF Margin stood at 69.72% in 2023, then tumbled by 646 bps to 380.78% in 2024, then sank by 835 bps to 3558.9% in 2025.
  • Per Business Quant, the three latest ACLX FCF Margin figures stand at 3558.9% (Q4 2025), 999.07% (Q3 2025), and 515.96% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - -3,558.90%

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,558.90%
Sep 30, 2025 -999.07%
Jun 30, 2025 -515.96%
Mar 31, 2025 -786.38%
Dec 31, 2024 -380.78%
Sep 30, 2024 149.94%
Jun 30, 2024 -144.11%
Mar 31, 2024 -97.66%
Dec 31, 2023 69.72%
Sep 30, 2023 -60.84%
Jun 30, 2023 -208.66%
Mar 31, 2023 1,010.84%